22years of experience


2200+projects


210+NDAs from NMPA, FDA and EMA


preferred CRO of 56 Global Clients

Request for Information

With 20 years of expertise, we provide comprehensive clinical research services, excelling in data management, statistical analysis, and pioneering advancements in Cell and Gene Therapy (CGT). Having led 2,200+ clinical projects and contributed to the approval of 210+ innovative drugs, we drive industry innovation and global patient benefits. Contact us for a free consultation.

Resources Center
CDE Release | Notice on Publicly Soliciting Opinions on the Technical Guidelines for Clinical Trials of Chimeric Antigen Receptor T Cell Therapy for Lymphatic and Hematological Malignant Tumors (Draft for Comments)
CDE Release | Notice on Publicly Soliciting Opinions on...

Date：

2024-08-02
Multiple chimeric antigen receptor T cell therapy products have been launched in China for the treatment of malignant tu...
READ MORE
Interpreting the roles and responsibilities of relevant personnel from the perspective of clinical trial data flow
Interpreting the roles and responsibilities of relevant...

Date：

2022-04-08
Clinical trial data can be defined as any information or fact related to a clinical trial. What information in our daily...
READ MORE
A Brief Analysis of the Multiple Issues in Clinical Trials
A Brief Analysis of the Multiple Issues in Clinical Tri...

Date：

2022-02-25
Clinical trials can be divided into "exploratory clinical trials" and "confirmatory clinical trials" according to differ...
READ MORE
A Brief Discussion on the Standardization Path of SDTM Finding Domain Program
A Brief Discussion on the Standardization Path of SDTM ...

Date：

2022-02-18
The processing rules for SDTM Finding Domain are relatively fixed, but in the actual project process, due to differences...
READ MORE
Creating CRF Template Library Based on CDASH
Creating CRF Template Library Based on CDASH

Date：

2022-02-11
We know that the quality of clinical trial data first and foremost depends on the quality of CRF. Therefore, in addition...
READ MORE